Koninklijke Philips N.V. (PHG)
Pre-Market:
| Previous Close | 25.12 |
| Open | 25.20 |
| Bid | 24.54 x 1800 |
| Ask | 24.67 x 900 |
| Day's Range | 24.94 - 25.33 |
| 52 Week Range | 23.07 - 57.65 |
| Volume | |
| Avg. Volume | 2,128,754 |
| Market Cap | 21.941B |
| Beta (5Y Monthly) | 0.84 |
| PE Ratio (TTM) | 6.83 |
| EPS (TTM) | 3.69 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.96 (3.84%) |
| Ex-Dividend Date | May 12, 2022 |
| 1y Target Est | 45.07 |
- GlobeNewswire
Philips Foundation publishes its 2021 Annual Report
Philips’ handheld point-of-care ultrasound platform Philips Foundation and SAS Brazil Philips Foundation working with Save the Children India May 25, 2022 Over 17 million people in underserved communities provided with access to quality healthcare in 2021 New social impact investment vehicle established to help nurture early-stage social enterprises Disaster relief in times of crisis highlighted by today’s humanitarian assistance to war-torn Ukraine, and projects responding to the COVID-19 pande
- Zacks
Philips' (PHG) Launches a Range of New Products at EuroPCR 2022
Philips' (PHG) launches innovative new solutions to attract customers amid a global supply crunch and drive top-line growth.
- GlobeNewswire
Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022
Philips Image Guided Therapy System – Azurion Philips intravascular ultrasound (IVUS) Philips iFR May 16, 2022 Co-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI) procedure planning, quantitative lesion measurement, stent choice and sizing, and therapy assessmentReduced need for contrast media enables broader access to PCI for patients at risk of acute kidney injuryUltra-lo
